Warren Heston

Patents Pending

2015, "PSMA-targeting imaging agents. " 14/605124, Xinning Wang, Steve Huang, & Warren Heston.

Publications

Wang, X., Huang, S., Heston, W., Guo, Z., Wang, H., & Basilion, J. (2014). Development of targeted near-infrared imaging agents for prostate cancer.. Molecular cancer therapeutics, 13 (11), 2595-606.
Huang, S., Wang, X., Zhang, Y., Doke, A., DiFilippo, F., & Heston, W. (2014). Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker.. The Prostate, 74 (7), 702-13.
Laydner, H., Huang, S., Heston, W., Autorino, R., Wang, X., Harsch, K., Magi-Galluzzi, C., Isac, W., Khanna, R., Hughes, B., Escobar, P., Chalikonda, S., Rao, P., Haber, G., Kaouk, J., & Feinstein, E. (2013). Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study.. Urology, 81 (2), 451-6.
Wang, X., Tian, H., Lee, Z., & Heston, W. (2012). Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists.. Nucleosides, nucleotides & nucleic acids, 31 (5), 432-44.
Wang, X., Mahanta, N., Olson, W., & Heston, W. (2011). In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.. Molecular cancer therapeutics, 10 (9), 1728-39.
Wang, X., Sayin, I., Rao, P., Feinstein, E., Harsch, K., Lee, Z., & Heston, W. (2007). Targeted treatment of prostate cancer.. Journal of cellular biochemistry, 102 (3), 571-9.
Durso, R., Andjelic, S., Gardner, J., Margitich, D., Donovan, G., Arrigale, R., Wang, X., Maughan, M., Talarico, T., Olmsted, R., Heston, W., Maddon, P., & Olson, W. (2007). A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (13), 3999-4008.
Cramer, H., Okicki, J., Rhoads, K. R., Wang, X. R., Silverman, E. R., & Heston, W. R. (2007). 2-5A ligands--a new concept for the treatment of prostate cancer.. Nucleosides, nucleotides & nucleic acids, 26 (10-12), 1471-7.
Jayaprakash, S., Wang, X., Heston, W., & Kozikowski, A. (2006). Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy.. ChemMedChem, 1 (3), 299-302.
Ghosh, A., Wang, X., Klein, M., & Heston, W. (2005). Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.. Cancer research, 65 (3), 727-31.